| Name | Title | Contact Details |
|---|---|---|
Matt Vanderpool |
Sr Director Product Development | Profile |
Connie Walsh |
Vice President Supply Chain and Vendor Partnerships | Profile |
Assessment Technologies Institute is a Stilwell, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We believe everyone deserves affordable and convenient healthcare. Our mission is to build better ways for people to find the right care at the best price. Our technology gives all Americans — regardless of income or insurance status — the knowledge, choice, and care they need to stay healthy. GoodRx supports all Americans with their healthcare challenges. Since 2011, we`ve helped Americans save over $35 billion on prescriptions via savings cards, our website, and the GoodRx app, which is one of the most downloaded medical apps on both the Google Play and Apple App Store. We`re a customer-first company. That means making sure all our products and features are built around you. This approach guides how we operate, make decisions across our businesses, and work on new ideas for our customers. In 2021, an estimated 46 million U.S. adults were not able to afford needed care. We`re working to narrow this access gap. We have saved Americans over $30 billion on their medications.
JW Nutritional strives to maintain a high quality of business from communication all the way to product fulfillment to ensure the success of our clients.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
ViaCirq, Inc. is a Canonsburg, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.